Want to see TSE:BBM full AI Analyst Report?
Top Page
Blueberries Medical
(BBM)
Select Model
Select Model
Rating:43Neutral
Price Target:
C$0.01
▼(-50.00% Downside)
Action:Reiterated
Date:08/05/26
The score is primarily constrained by weak financial performance—large ongoing losses, sharp revenue volatility, and continued cash burn—despite improved leverage. Technical momentum is positive but not fully confirmed by trend (price remains below longer-term moving averages). Valuation is also limited by negative earnings and no dividend support.
Positive Factors
Low Leverage / De-risked Capital Structure
TTM debt-to-equity ~0.02 signals a materially de‑risked capital structure, lowering refinancing and interest risk. For a cash-burning specialty drug maker, low leverage preserves optionality to raise capital or sustain operations through development cycles without immediate solvency pressure.
Negative Factors
Severe Revenue Decline
A ~-400% TTM revenue fall signals loss of scale and highly unstable demand. Durable recovery of margins and R&D return on investment depends on consistent top-line growth; persistent volatility makes long-term planning, fixed-cost absorption, and product commercialization far more challenging.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / De-risked Capital Structure
TTM debt-to-equity ~0.02 signals a materially de‑risked capital structure, lowering refinancing and interest risk. For a cash-burning specialty drug maker, low leverage preserves optionality to raise capital or sustain operations through development cycles without immediate solvency pressure.
Read all positive factors
Blueberries Medical (BBM) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$9.90M
Dividend YieldN/A
Average Volume (3M)5.76K
Price to Earnings (P/E)―
Beta (1Y)-2.77
Revenue Growth-31.51%
EPS Growth50.00%
CountryCA
Employees51
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume100
30 Day Avg. Volume5,759
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Blueberries Medical Business Overview & Revenue Model
Company Description
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis ...
Blueberries Medical Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
14
Very Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 312.29K | 471.41K | 288.27K | 235.45K | 138.75K |
| Gross Profit | 49.50K | 164.52K | 84.22K | -17.72K | -245.45K |
| EBITDA | -1.28M | -1.04M | -1.22M | -811.47K | -4.05M |
| Net Income | -1.67M | -1.15M | -1.64M | -1.47M | -5.15M |
Balance Sheet | |||||
| Total Assets | 679.62K | 1.38M | 2.42M | 3.35M | 3.59M |
| Cash, Cash Equivalents and Short-Term Investments | 26.39K | 66.08K | 818.16K | 1.41M | 1.34M |
| Total Debt | 137.88K | 11.44K | 12.80K | 1.34M | 1.44M |
| Total Liabilities | 358.45K | 545.61K | 470.72K | 1.89M | 2.16M |
| Stockholders Equity | 321.17K | 834.81K | 1.95M | 1.47M | 1.43M |
Cash Flow | |||||
| Free Cash Flow | -1.24M | -796.85K | -1.35M | -1.47M | -1.73M |
| Operating Cash Flow | -1.24M | -796.85K | -1.33M | -1.47M | -1.68M |
| Investing Cash Flow | 0.00 | 9.00K | 382.92K | 101.94K | -48.77K |
| Financing Cash Flow | 1.18M | -1.95K | 539.10K | 1.35M | 2.77M |
Blueberries Medical Technical Analysis
Positive
0.02
Price Trends
0.01
Positive
0.01
Positive
0.01
Positive
Market Momentum
<0.01
Positive
52.53
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BBM, the sentiment is Positive. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.01, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 52.53 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:BBM.
Blueberries Medical Peers Comparison
UnderperformOutperform
Sector (51)
TSE:BBM
Blueberries Medical
0.02
<0.01
50.00%
TSE:MVMD
Mountain Valley MD
0.08
0.06
400.00%
TSE:BAMM
Body & Mind
0.03
0.00
0.00%
TSE:CDVA
CordovaCann
0.03
-0.03
-58.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.